The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Chan Heng Fai Ambrose | Director, 10% Owner | Other(J) | 16.6M | $0.93 | $15.4M |
| Aug 28, 2025 | Chan Heng Fai Ambrose | Director, 10% Owner | Buy(S) | 131K | $1.35 | $176K |
| Aug 20, 2025 | Alset Inc. | 10% Owner | Other(J) | 0 | — | — |
| Feb 6, 2025 | Chan Heng Fai Ambrose | Director, 10% Owner | Grant(A) | 1.0M | — | $0 |
| Dec 10, 2024 | Chan Heng Fai Ambrose | Director, 10% Owner | Buy(P) | 205K | $0.97 | $199K |
| Dec 10, 2024 | Chan Heng Fai Ambrose | Director, 10% Owner | Buy(P) | 821K | $0.97 | $796K |
| Dec 29, 2023 | Wu William Wai Leung | Director | Sell(S) | 1K | $0.13 | $133 |
| Dec 29, 2023 | Wu William Wai Leung | Director | Sell(S) | 150K | $0.13 | $20K |
| Dec 28, 2023 | Chan Heng Fai Ambrose | Director, 10% Owner | Buy(P) | 672K | $0.15 | $101K |
| Apr 10, 2023 | Heuszel Frank D | Chief Executive Officer, Director | Grant(A) | 1.2M | $0.22 | $274K |
| Dec 13, 2022 | Chan Heng Fai Ambrose | Director, 10% Owner | Buy(P) | 335K | $0.23 | $77K |
| Dec 9, 2022 | Chan Heng Fai Ambrose | Director, 10% Owner | Buy(P) | 51K | $0.19 | $10K |
| Jul 12, 2022 | Alset International Ltd | 10% Owner | Other(J) | 21.4M | — | — |
| Jul 7, 2022 | Chan Heng Fai Ambrose | Director, 10% Owner | Buy(P) | 17.6M | — | — |
| Jun 17, 2022 | Wu William Wai Leung | Director | Buy(P) | 5K | $0.38 | $2K |
| Jun 16, 2022 | Wu William Wai Leung | Director | Buy(P) | 5K | $0.38 | $2K |
| Jun 10, 2022 | Wu William Wai Leung | Director | Buy(P) | 27K | $0.41 | $11K |
| Jun 9, 2022 | Wu William Wai Leung | Director | Buy(P) | 73K | $0.42 | $30K |
| Jun 8, 2022 | Wu William Wai Leung | Director | Buy(P) | 24K | $0.41 | $10K |
| Jun 7, 2022 | Wu William Wai Leung | Director | Buy(P) | 17K | $0.39 | $7K |
| May 25, 2022 | Chan Heng Fai Ambrose | Director, 10% Owner | Grant(A) | 15.4M | — | — |
| May 4, 2022 | Heuszel Frank D | Chief Executive Officer, Director | Grant(A) | 63K | $0.45 | $28K |
| Apr 1, 2022 | Chan Heng Fai Ambrose | Director, 10% Owner | Grant(A) | 894K | — | — |
| Mar 9, 2022 | Chan Heng Fai Ambrose | Director, 10% Owner | Buy(P) | 4.0M | $0.38 | $1.5M |
| Sep 8, 2021 | Chan Heng Fai Ambrose | Director, 10% Owner | Buy(P) | 12.2M | $1.23 | $15.0M |
| Jun 21, 2021 | Global BioMedical Pte. Ltd. | 10% Owner | Conversion(C) | 7K | — | — |
| Jun 21, 2021 | Global BioMedical Pte. Ltd. | 10% Owner | Conversion(C) | 1.1M | — | — |
| Jun 16, 2021 | Chan Heng Fai Ambrose | Director, 10% Owner | Buy(P) | 555K | $1.70 | $944K |
| Jun 15, 2021 | Chan Heng Fai Ambrose | Director, 10% Owner | Buy(P) | 116K | $1.77 | $205K |
| Jun 15, 2021 | Chan Heng Fai Ambrose | Director, 10% Owner | Buy(P) | 884K | $1.69 | $1.5M |
| May 26, 2021 | Chan Heng Fai Ambrose | Director, 10% Owner | Conversion(C) | 35K | — | — |
| May 26, 2021 | Chan Heng Fai Ambrose | Director, 10% Owner | Conversion(C) | 5.5M | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).